Press & Media

Latest news:

2024-06-19

FSG Fund II AB – SFDR Report

2023-09-01

FSG Fund II AB – Pressrelease First Close

2023-02-16

Merck signs on to Aqilion’s autoimmune project in €950M deal 

2022-10-14

Fåhraeus Startup & Growth AB invests in the digital obesity clinic Yazen Health (in Swedish)

2022-05-27

Notice of Annual General Meeting in Fåhraeus Startup & Growth AB (In Swedish)

Fullmakt – Power of Attorney

Annual Report 2021 Fåhraeus Startup & Growth AB

2022-05-03

Fåhraeus Startup & Growth invests in Melius Pharma’s phase IIa study for the treatment of Idiopathic pulmonary fibrosis (IPF) (in Swedish)

2022-03-14

Fåhraeus Startup & Growth invests in Nygen Analytics’ cloud-based platform for complete analysis of single-cell data (in Swedish)

2022-02-23

Fåhraeus Startup & Growth invests in Saveggy’s edible alternatives to plastic film (in Swedish)

2022-02-16

Moroxite F has raised its first external capital to finance preparatory clinical studies (in Swedish)

2022-02-01

Oncorena Initiates the Phase I-II Clinical Trial with Orellanine in Advanced Kidney Cancer Patients at Karolinska University Hospital in Sweden.

2022-01-14

Series entrepreneur Christer Fåhraeus is investing in power bank-sharing (in Swedish).

2021-12-17

 

Fåhraeus Startup & Growth AB invests in Oncorena – whose drug candidate has the potential to revolutionize the treatment of advanced kidney cancer (in Swedish)

2021-10-27

Intuicell’s system – “As close to the brain as you can get” (In Swedish).

2021-07-01

They build AI like the human brain – “today’s applications are stupid” (in Swedish).